| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T76 |
0-350 |
Sentence |
denotes |
Immune classification of patients with SARS-CoV-2 was performed by using the tools suggested for bacterial sepsis, i.e., ferritin more than 4,420 ng/mL for MAS (Kyriazopoulou et al., 2017), and HLA-DR molecules on CD14 monocytes lower than 5,000, in the absence of elevated ferritin, for the immune dysregulation phenotype (Lukaszewicz et al., 2009). |
| T77 |
351-509 |
Sentence |
denotes |
It was found that contrary to the patients with bacterial CAP and SRF, all patients with SRF and SARS-CoV-2 had either immune dysregulation or MAS (Table 2 ). |
| T78 |
510-668 |
Sentence |
denotes |
Table 2 Association between Severe Respiratory Failure and Immune Classification among Patients with COVID-19 and Patients with Sepsis Caused by Bacterial CAP |
| T79 |
669-744 |
Sentence |
denotes |
Number of patients with SRF/total patients [%, (−95% CI, +95% CI)] p value∗ |
| T80 |
745-767 |
Sentence |
denotes |
Bacterial CAP COVID-19 |
| T81 |
768-831 |
Sentence |
denotes |
Intermediate 21/40 [52.5 (27.5-67.1)] 0/26 [0 (0-12.9)] <0.0001 |
| T82 |
832-970 |
Sentence |
denotes |
Immunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] <0.0001 |
| T83 |
971-1009 |
Sentence |
denotes |
∗comparisons by the Fisher exact test. |
| T84 |
1010-1062 |
Sentence |
denotes |
Abbreviation is as follows: CI, confidence interval. |
